|
CUL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.016700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.502100E-03 |
| Normal-vs-Stage2 |
9.485800E-02 |
| Normal-vs-Stage3 |
1.87415999999274E-05 |
| Normal-vs-Stage4 |
7.782200E-02 |
| Stage1-vs-Stage2 |
9.343200E-01 |
| Stage1-vs-Stage3 |
8.975800E-03 |
| Stage1-vs-Stage4 |
9.528400E-01 |
| Stage2-vs-Stage3 |
1.033390E-01 |
| Stage2-vs-Stage4 |
9.844000E-01 |
| Stage3-vs-Stage4 |
1.114760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.158100E-04 |
| Normal-vs-AfricanAmerican |
5.217000E-04 |
| Normal-vs-Asian |
7.052000E-01 |
| Caucasian-vs-AfricanAmerican |
1.843770E-01 |
| Caucasian-vs-Asian |
1.945950E-01 |
| AfricanAmerican-vs-Asian |
7.632200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.102390E-03 |
| Normal-vs-Female |
2.280200E-03 |
| Male-vs-Female |
8.722000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.618340E-02 |
| Normal-vs-Age(41-60Yrs) |
1.093590E-02 |
| Normal-vs-Age(61-80Yrs) |
1.264430E-03 |
| Normal-vs-Age(81-100Yrs) |
1.124060E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.153600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.111800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.388400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.906400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.121700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.696600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.406600E-01 |
| Normal-vs-Grade 2 |
2.118400E-02 |
| Normal-vs-Grade 3 |
3.61680000000586E-05 |
| Normal-vs-Grade 4 |
2.739900E-02 |
| Grade 1-vs-Grade 2 |
5.616800E-01 |
| Grade 1-vs-Grade 3 |
1.051570E-01 |
| Grade 1-vs-Grade 4 |
2.364600E-01 |
| Grade 2-vs-Grade 3 |
1.570150E-02 |
| Grade 2-vs-Grade 4 |
4.206400E-01 |
| Grade 3-vs-Grade 4 |
6.274200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.230100E-02 |
| Normal-vs-ccB subtype |
1.578140E-03 |
| ccA subtype-vs-ccB subtype |
1.199570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.438400E-03 |
| Normal-vs-N1 |
9.726600E-01 |
| N0-vs-N1 |
2.223800E-01 |
|
|
